In several on-going clinical studies, granulocyte-colony stimulating factors (G-CSF) is used in alcoholic hepatitis patients to examine its safety and efficacy (NCT03703674/ NCT02442180). This evidence concerns the gene CSF3 and alcoholic hepatitis.